Skip to main content
European Commission logo print header

Proof Of Concept Use of MTH1 Inhibitors as New Treatments for cancer

Objective

"In our ERC grant GEnetic NEtworks as a tool for anti-CAncer Drug Development we used phenotypic screening and genetic networks to identify the DNA repair protein MTH1 as a critical component for cancer cell survival and we developed selective sub nM inhibitors to MTH1, which specifically kill cancer cells and tumours, whilst being less toxic to primary cells. Our approach provides a novel concept for treating cancer. Here, we want to explore the commercial potential of the MTH1 inhibitors identified in the ERC grant."

Call for proposal

ERC-2013-PoC
See other projects for this call

Host institution

KAROLINSKA INSTITUTET
EU contribution
€ 105 990,00
Address
Nobels Vag 5
17177 Stockholm
Sweden

See on map

Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Jill Blomstrand (Mrs.)
Links
Total cost
No data

Beneficiaries (2)